Skip to content
MedsAcross

Medicine

Sulfacetamide 100 mg/mL eye drops

Sulfacetamide · Ophthalmic
Available on requestPrescription onlyUS FDAGeneric name

Sulfacetamide 100 mg/mL eye drops is a generic prescription medicine for ophthalmic use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store between 2° to 25°C (36° to 77°F).

Key facts

Active ingredient (INN)
Sulfacetamide
Brand
Sold under the generic name
Strength
100 mg/mL
Dosage form
Eye drops
Route
Ophthalmic
Packs
1 bottle, 15 mL and 3 more
Manufacturers
A-S Medication SolutionsAsclemedBausch & LombNuCare Pharmaceuticals,IncPreferred PharmaceuticalsProficient Rx
Origin register
US FDA, United States
Storage
Store between 2° to 25°C (36° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D10AF06 Sulfacetamide
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 December 1994
Identifiers
RxCUI 1006120DailyMed set ID 2b4f125c-338e-479f-8feb-b82324230c65, 9910ec80-e37c-6a83-e053-2995a90a8237, 6c1b2658-e756-4f31-9bc8-f99a0baa4637 +3NDC 71205-689, 68071-5123, 24208-670 +3Application ANDA040066

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper24208-670-04Bausch & Lomb28 December 1994
1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper50090-0246-0A-S Medication Solutions29 June 2016
15 mL in 1 bottle, dropper76420-090-15Asclemed24 October 2020
15 mL in 1 bottle, dropper68071-5123-5NuCare Pharmaceuticals,Inc6 December 2019
15 mL in 1 bottle, dropper68788-9871-1Preferred Pharmaceuticals28 February 2012
1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper71205-689-15Proficient Rx26 August 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 July 1946Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Sulfacetamide

Clinical summary

Sulfacetamide is a sulfonamide antibacterial indicated in the topical treatment of acne vulgaris. It is available as eye drops, lotion and ophthalmic solution for topical use. MedsAcross supplies Sulfacetamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Sulfacetamide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Sulfacetamide 100 mg/mL eye drops for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.